APO Research
Talk to an analyst

APO RESEARCH · REPORT

Over the Counter (OTC) Analgesics

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Over the Counter (OTC) Analgesics Market Analysis and Forecast 2026-2032

31 December 2025195 pages

Choose your research edition.

Industry ResearchOver the Counter (OTC) Analgesics Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Over the Counter (OTC) Analgesics Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Over the Counter (OTC) Analgesics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Over the Counter (OTC) Analgesics Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Over the Counter (OTC) Analgesics Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Over the Counter (OTC) Analgesics market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Over the Counter (OTC) Analgesics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Over the Counter (OTC) Analgesics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Over the Counter (OTC) Analgesics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Over the Counter (OTC) Analgesics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Over the Counter (OTC) Analgesics include Takeda Pharmaceutical Company Limited., Sanofi SA, Johnson & Johnson, Novartis, Pfizer, Bayer AG, AstraZeneca, Sun Pharma and Reckitt Benckiser Group PLC, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Over the Counter (OTC) Analgesics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Over the Counter (OTC) Analgesics, also provides the sales of main regions and countries. Of the upcoming market potential for Over the Counter (OTC) Analgesics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Over the Counter (OTC) Analgesics sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Over the Counter (OTC) Analgesics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Over the Counter (OTC) Analgesics sales, projected growth trends, production technology, application and end-user industry.

Over the Counter (OTC) Analgesics Segment by Company

Takeda Pharmaceutical Company Limited.

Sanofi SA

Johnson & Johnson

Novartis

Pfizer

Bayer AG

AstraZeneca

Sun Pharma

Reckitt Benckiser Group PLC

GlaxoSmithKline PLC

Boehringer Ingelheim International GmbH

Over the Counter (OTC) Analgesics Segment by Type

Tablet

Capsule

Other

Over the Counter (OTC) Analgesics Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Over the Counter (OTC) Analgesics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Over the Counter (OTC) Analgesics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Over the Counter (OTC) Analgesics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Over the Counter (OTC) Analgesics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Over the Counter (OTC) Analgesics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Over the Counter (OTC) Analgesics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Over the Counter (OTC) Analgesics sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Over the Counter (OTC) Analgesics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Tablet Major Manufacturers Table 3. Capsule Major Manufacturers Table 4. Other Major Manufacturers Table 5. Global Over the Counter (OTC) Analgesics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Retail Pharmacies Major Manufacturers Table 7. Online Pharmacies Major Manufacturers Table 8. Hospital Pharmacies Major Manufacturers Table 9. Over the Counter (OTC) Analgesics Industry Trends Table 10. Over the Counter (OTC) Analgesics Industry Drivers Table 11. Over the Counter (OTC) Analgesics Industry Opportunities and Challenges Table 12. Over the Counter (OTC) Analgesics Industry Restraints Table 13. Global Over the Counter (OTC) Analgesics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Over the Counter (OTC) Analgesics Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Over the Counter (OTC) Analgesics Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Over the Counter (OTC) Analgesics Revenue Market Share by Region (2021-2026) Table 17. Global Over the Counter (OTC) Analgesics Revenue Market Share by Region (2027-2032) Table 18. Global Over the Counter (OTC) Analgesics Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Over the Counter (OTC) Analgesics Sales by Region (2021-2026) & (K Units) Table 20. Global Over the Counter (OTC) Analgesics Sales by Region (2027-2032) & (K Units) Table 21. Global Over the Counter (OTC) Analgesics Sales Market Share by Region (2021-2026) Table 22. Global Over the Counter (OTC) Analgesics Sales Market Share by Region (2027-2032) Table 23. Global Over the Counter (OTC) Analgesics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Over the Counter (OTC) Analgesics Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Over the Counter (OTC) Analgesics Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Over the Counter (OTC) Analgesics Sales Market Share by Manufacturers (2021-2026) Table 27. Global Over the Counter (OTC) Analgesics Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Over the Counter (OTC) Analgesics Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Over the Counter (OTC) Analgesics Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Over the Counter (OTC) Analgesics Manufacturers, Product Type & Application Table 31. Global Over the Counter (OTC) Analgesics Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Over the Counter (OTC) Analgesics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Over the Counter (OTC) Analgesics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Over the Counter (OTC) Analgesics Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Over the Counter (OTC) Analgesics Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Over the Counter (OTC) Analgesics Revenue Market Share by Type (2021-2026) Table 38. Global Over the Counter (OTC) Analgesics Revenue Market Share by Type (2027-2032) Table 39. Global Over the Counter (OTC) Analgesics Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Over the Counter (OTC) Analgesics Sales by Type (2021-2026) & (K Units) Table 41. Global Over the Counter (OTC) Analgesics Sales by Type (2027-2032) & (K Units) Table 42. Global Over the Counter (OTC) Analgesics Sales Market Share by Type (2021-2026) Table 43. Global Over the Counter (OTC) Analgesics Sales Market Share by Type (2027-2032) Table 44. Global Over the Counter (OTC) Analgesics Price by Type (2021-2026) & (US$/Unit) Table 45. Global Over the Counter (OTC) Analgesics Price by Type (2027-2032) & (US$/Unit) Table 46. Global Over the Counter (OTC) Analgesics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Over the Counter (OTC) Analgesics Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Over the Counter (OTC) Analgesics Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Over the Counter (OTC) Analgesics Revenue Market Share by Application (2021-2026) Table 50. Global Over the Counter (OTC) Analgesics Revenue Market Share by Application (2027-2032) Table 51. Global Over the Counter (OTC) Analgesics Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Over the Counter (OTC) Analgesics Sales by Application (2021-2026) & (K Units) Table 53. Global Over the Counter (OTC) Analgesics Sales by Application (2027-2032) & (K Units) Table 54. Global Over the Counter (OTC) Analgesics Sales Market Share by Application (2021-2026) Table 55. Global Over the Counter (OTC) Analgesics Sales Market Share by Application (2027-2032) Table 56. Global Over the Counter (OTC) Analgesics Price by Application (2021-2026) & (US$/Unit) Table 57. Global Over the Counter (OTC) Analgesics Price by Application (2027-2032) & (US$/Unit) Table 58. Takeda Pharmaceutical Company Limited. Company Information Table 59. Takeda Pharmaceutical Company Limited. Business Overview Table 60. Takeda Pharmaceutical Company Limited. Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Takeda Pharmaceutical Company Limited. Over the Counter (OTC) Analgesics Product Portfolio Table 62. Takeda Pharmaceutical Company Limited. Recent Development Table 63. Sanofi SA Company Information Table 64. Sanofi SA Business Overview Table 65. Sanofi SA Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Sanofi SA Over the Counter (OTC) Analgesics Product Portfolio Table 67. Sanofi SA Recent Development Table 68. Johnson & Johnson Company Information Table 69. Johnson & Johnson Business Overview Table 70. Johnson & Johnson Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Johnson & Johnson Over the Counter (OTC) Analgesics Product Portfolio Table 72. Johnson & Johnson Recent Development Table 73. Novartis Company Information Table 74. Novartis Business Overview Table 75. Novartis Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Novartis Over the Counter (OTC) Analgesics Product Portfolio Table 77. Novartis Recent Development Table 78. Pfizer Company Information Table 79. Pfizer Business Overview Table 80. Pfizer Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Pfizer Over the Counter (OTC) Analgesics Product Portfolio Table 82. Pfizer Recent Development Table 83. Bayer AG Company Information Table 84. Bayer AG Business Overview Table 85. Bayer AG Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Bayer AG Over the Counter (OTC) Analgesics Product Portfolio Table 87. Bayer AG Recent Development Table 88. AstraZeneca Company Information Table 89. AstraZeneca Business Overview Table 90. AstraZeneca Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. AstraZeneca Over the Counter (OTC) Analgesics Product Portfolio Table 92. AstraZeneca Recent Development Table 93. Sun Pharma Company Information Table 94. Sun Pharma Business Overview Table 95. Sun Pharma Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Sun Pharma Over the Counter (OTC) Analgesics Product Portfolio Table 97. Sun Pharma Recent Development Table 98. Reckitt Benckiser Group PLC Company Information Table 99. Reckitt Benckiser Group PLC Business Overview Table 100. Reckitt Benckiser Group PLC Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Reckitt Benckiser Group PLC Over the Counter (OTC) Analgesics Product Portfolio Table 102. Reckitt Benckiser Group PLC Recent Development Table 103. GlaxoSmithKline PLC Company Information Table 104. GlaxoSmithKline PLC Business Overview Table 105. GlaxoSmithKline PLC Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. GlaxoSmithKline PLC Over the Counter (OTC) Analgesics Product Portfolio Table 107. GlaxoSmithKline PLC Recent Development Table 108. Boehringer Ingelheim International GmbH Company Information Table 109. Boehringer Ingelheim International GmbH Business Overview Table 110. Boehringer Ingelheim International GmbH Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Boehringer Ingelheim International GmbH Over the Counter (OTC) Analgesics Product Portfolio Table 112. Boehringer Ingelheim International GmbH Recent Development Table 113. North America Over the Counter (OTC) Analgesics Revenue by Type (2021-2026) & (US$ Million) Table 114. North America Over the Counter (OTC) Analgesics Revenue by Type (2027-2032) & (US$ Million) Table 115. North America Over the Counter (OTC) Analgesics Sales by Type (2021-2026) & (K Units) Table 116. North America Over the Counter (OTC) Analgesics Sales by Type (2027-2032) & (K Units) Table 117. North America Over the Counter (OTC) Analgesics Sales Price by Type (2021-2026) & (US$/Unit) Table 118. North America Over the Counter (OTC) Analgesics Sales Price by Type (2027-2032) & (US$/Unit) Table 119. North America Over the Counter (OTC) Analgesics Revenue by Application (2021-2026) & (US$ Million) Table 120. North America Over the Counter (OTC) Analgesics Revenue by Application (2027-2032) & (US$ Million) Table 121. North America Over the Counter (OTC) Analgesics Sales by Application (2021-2026) & (K Units) Table 122. North America Over the Counter (OTC) Analgesics Sales by Application (2027-2032) & (K Units) Table 123. North America Over the Counter (OTC) Analgesics Sales Price by Application (2021-2026) & (US$/Unit) Table 124. North America Over the Counter (OTC) Analgesics Sales Price by Application (2027-2032) & (US$/Unit) Table 125. North America Over the Counter (OTC) Analgesics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. North America Over the Counter (OTC) Analgesics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 127. North America Over the Counter (OTC) Analgesics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 128. North America Over the Counter (OTC) Analgesics Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 129. North America Over the Counter (OTC) Analgesics Sales by Country (2021-2026) & (K Units) Table 130. North America Over the Counter (OTC) Analgesics Sales by Country (2027-2032) & (K Units) Table 131. North America Over the Counter (OTC) Analgesics Sales Price by Country (2021-2026) & (US$/Unit) Table 132. North America Over the Counter (OTC) Analgesics Sales Price by Country (2027-2032) & (US$/Unit) Table 133. United States Over the Counter (OTC) Analgesics Revenue (2021-2032) & (US$ Million) Table 134. Canada Over the Counter (OTC) Analgesics Revenue (2021-2032) & (US$ Million) Table 135. Europe Over the Counter (OTC) Analgesics Revenue by Type (2021-2026) & (US$ Million) Table 136. Europe Over the Counter (OTC) Analgesics Revenue by Type (2027-2032) & (US$ Million) Table 137. Europe Over the Counter (OTC) Analgesics Sales by Type (2021-2026) & (K Units) Table 138. Europe Over the Counter (OTC) Analgesics Sales by Type (2027-2032) & (K Units) Table 139. Europe Over the Counter (OTC) Analgesics Sales Price by Type (2021-2026) & (US$/Unit) Table 140. Europe Over the Counter (OTC) Analgesics Sales Price by Type (2027-2032) & (US$/Unit) Table 141. Europe Over the Counter (OTC) Analgesics Revenue by Application (2021-2026) & (US$ Million) Table 142. Europe Over the Counter (OTC) Analgesics Revenue by Application (2027-2032) & (US$ Million) Table 143. Europe Over the Counter (OTC) Analgesics Sales by Application (2021-2026) & (K Units) Table 144. Europe Over the Counter (OTC) Analgesics Sales by Application (2027-2032) & (K Units) Table 145. Europe Over the Counter (OTC) Analgesics Sales Price by Application (2021-2026) & (US$/Unit) Table 146. Europe Over the Counter (OTC) Analgesics Sales Price by Application (2027-2032) & (US$/Unit) Table 147. Europe Over the Counter (OTC) Analgesics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Europe Over the Counter (OTC) Analgesics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 149. Europe Over the Counter (OTC) Analgesics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 150. Europe Over the Counter (OTC) Analgesics Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 151. Europe Over the Counter (OTC) Analgesics Sales by Country (2021-2026) & (K Units) Table 152. Europe Over the Counter (OTC) Analgesics Sales by Country (2027-2032) & (K Units) Table 153. Europe Over the Counter (OTC) Analgesics Sales Price by Country (2021-2026) & (US$/Unit) Table 154. Europe Over the Counter (OTC) Analgesics Sales Price by Country (2027-2032) & (US$/Unit) Table 155. Germany Over the Counter (OTC) Analgesics Revenue (2021-2032) & (US$ Million) Table 156. France Over the Counter (OTC) Analgesics Revenue (2021-2032) & (US$ Million) Table 157. U.K. Over the Counter (OTC) Analgesics Revenue (2021-2032) & (US$ Million) Table 158. Italy Over the Counter (OTC) Analgesics Revenue (2021-2032) & (US$ Million) Table 159. Netherlands Over the Counter (OTC) Analgesics Revenue (2021-2032) & (US$ Million) Table 160. China Over the Counter (OTC) Analgesics Revenue by Type (2021-2026) & (US$ Million) Table 161. China Over the Counter (OTC) Analgesics Revenue by Type (2027-2032) & (US$ Million) Table 162. China Over the Counter (OTC) Analgesics Sales by Type (2021-2026) & (K Units) Table 163. China Over the Counter (OTC) Analgesics Sales by Type (2027-2032) & (K Units) Table 164. China Over the Counter (OTC) Analgesics Sales Price by Type (2021-2026) & (US$/Unit) Table 165. China Over the Counter (OTC) Analgesics Sales Price by Type (2027-2032) & (US$/Unit) Table 166. China Over the Counter (OTC) Analgesics Revenue by Application (2021-2026) & (US$ Million) Table 167. China Over the Counter (OTC) Analgesics Revenue by Application (2027-2032) & (US$ Million) Table 168. China Over the Counter (OTC) Analgesics Sales by Application (2021-2026) & (K Units) Table 169. China Over the Counter (OTC) Analgesics Sales by Application (2027-2032) & (K Units) Table 170. China Over the Counter (OTC) Analgesics Sales Price by Application (2021-2026) & (US$/Unit) Table 171. China Over the Counter (OTC) Analgesics Sales Price by Application (2027-2032) & (US$/Unit) Table 172. Asia Over the Counter (OTC) Analgesics Revenue by Type (2021-2026) & (US$ Million) Table 173. Asia Over the Counter (OTC) Analgesics Revenue by Type (2027-2032) & (US$ Million) Table 174. Asia Over the Counter (OTC) Analgesics Sales by Type (2021-2026) & (K Units) Table 175. Asia Over the Counter (OTC) Analgesics Sales by Type (2027-2032) & (K Units) Table 176. Asia Over the Counter (OTC) Analgesics Sales Price by Type (2021-2026) & (US$/Unit) Table 177. Asia Over the Counter (OTC) Analgesics Sales Price by Type (2027-2032) & (US$/Unit) Table 178. Asia Over the Counter (OTC) Analgesics Revenue by Application (2021-2026) & (US$ Million) Table 179. Asia Over the Counter (OTC) Analgesics Revenue by Application (2027-2032) & (US$ Million) Table 180. Asia Over the Counter (OTC) Analgesics Sales by Application (2021-2026) & (K Units) Table 181. Asia Over the Counter (OTC) Analgesics Sales by Application (2027-2032) & (K Units) Table 182. Asia Over the Counter (OTC) Analgesics Sales Price by Application (2021-2026) & (US$/Unit) Table 183. Asia Over the Counter (OTC) Analgesics Sales Price by Application (2027-2032) & (US$/Unit) Table 184. Asia Over the Counter (OTC) Analgesics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. Asia Over the Counter (OTC) Analgesics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. Asia Over the Counter (OTC) Analgesics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. Asia Over the Counter (OTC) Analgesics Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 188. Asia Over the Counter (OTC) Analgesics Sales by Country (2021-2026) & (K Units) Table 189. Asia Over the Counter (OTC) Analgesics Sales by Country (2027-2032) & (K Units) Table 190. Asia Over the Counter (OTC) Analgesics Sales Price by Country (2021-2026) & (US$/Unit) Table 191. Asia Over the Counter (OTC) Analgesics Sales Price by Country (2027-2032) & (US$/Unit) Table 192. Japan Over the Counter (OTC) Analgesics Revenue (2021-2032) & (US$ Million) Table 193. South Korea Over the Counter (OTC) Analgesics Revenue (2021-2032) & (US$ Million) Table 194. India Over the Counter (OTC) Analgesics Revenue (2021-2032) & (US$ Million) Table 195. Australia Over the Counter (OTC) Analgesics Revenue (2021-2032) & (US$ Million) Table 196. China Taiwan Over the Counter (OTC) Analgesics Revenue (2021-2032) & (US$ Million) Table 197. Southeast Asia Over the Counter (OTC) Analgesics Revenue (2021-2032) & (US$ Million) Table 198. SAMEA Over the Counter (OTC) Analgesics Revenue by Type (2021-2026) & (US$ Million) Table 199. SAMEA Over the Counter (OTC) Analgesics Revenue by Type (2027-2032) & (US$ Million) Table 200. SAMEA Over the Counter (OTC) Analgesics Sales by Type (2021-2026) & (K Units) Table 201. SAMEA Over the Counter (OTC) Analgesics Sales by Type (2027-2032) & (K Units) Table 202. SAMEA Over the Counter (OTC) Analgesics Sales Price by Type (2021-2026) & (US$/Unit) Table 203. SAMEA Over the Counter (OTC) Analgesics Sales Price by Type (2027-2032) & (US$/Unit) Table 204. SAMEA Over the Counter (OTC) Analgesics Revenue by Application (2021-2026) & (US$ Million) Table 205. SAMEA Over the Counter (OTC) Analgesics Revenue by Application (2027-2032) & (US$ Million) Table 206. SAMEA Over the Counter (OTC) Analgesics Sales by Application (2021-2026) & (K Units) Table 207. SAMEA Over the Counter (OTC) Analgesics Sales by Application (2027-2032) & (K Units) Table 208. SAMEA Over the Counter (OTC) Analgesics Sales Price by Application (2021-2026) & (US$/Unit) Table 209. SAMEA Over the Counter (OTC) Analgesics Sales Price by Application (2027-2032) & (US$/Unit) Table 210. SAMEA Over the Counter (OTC) Analgesics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 211. SAMEA Over the Counter (OTC) Analgesics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 212. SAMEA Over the Counter (OTC) Analgesics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 213. SAMEA Over the Counter (OTC) Analgesics Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 214. SAMEA Over the Counter (OTC) Analgesics Sales by Country (2021-2026) & (K Units) Table 215. SAMEA Over the Counter (OTC) Analgesics Sales by Country (2027-2032) & (K Units) Table 216. SAMEA Over the Counter (OTC) Analgesics Sales Price by Country (2021-2026) & (US$/Unit) Table 217. SAMEA Over the Counter (OTC) Analgesics Sales Price by Country (2027-2032) & (US$/Unit) Table 218. Brazil Over the Counter (OTC) Analgesics Revenue (2021-2032) & (US$ Million) Table 219. Argentina Over the Counter (OTC) Analgesics Revenue (2021-2032) & (US$ Million) Table 220. Chile Over the Counter (OTC) Analgesics Revenue (2021-2032) & (US$ Million) Table 221. Colombia Over the Counter (OTC) Analgesics Revenue (2021-2032) & (US$ Million) Table 222. Peru Over the Counter (OTC) Analgesics Revenue (2021-2032) & (US$ Million) Table 223. Saudi Arabia Over the Counter (OTC) Analgesics Revenue (2021-2032) & (US$ Million) Table 224. Israel Over the Counter (OTC) Analgesics Revenue (2021-2032) & (US$ Million) Table 225. UAE Over the Counter (OTC) Analgesics Revenue (2021-2032) & (US$ Million) Table 226. Turkey Over the Counter (OTC) Analgesics Revenue (2021-2032) & (US$ Million) Table 227. Iran Over the Counter (OTC) Analgesics Revenue (2021-2032) & (US$ Million) Table 228. Egypt Over the Counter (OTC) Analgesics Revenue (2021-2032) & (US$ Million) Table 229. Key Raw Materials Table 230. Raw Materials Key Suppliers Table 231. Over the Counter (OTC) Analgesics Distributors List Table 232. Over the Counter (OTC) Analgesics Customers List Table 233. Research Programs/Design for This Report Table 234. Authors List of This Report Table 235. Secondary Sources Table 236. Primary Sources List of Figures Figure 1. Over the Counter (OTC) Analgesics Image Figure 2. Global Over the Counter (OTC) Analgesics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Over the Counter (OTC) Analgesics Market Size Share 2021 VS 2025 VS 2032 Figure 4. Tablet Image Figure 5. Capsule Image Figure 6. Other Image Figure 7. Global Over the Counter (OTC) Analgesics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Over the Counter (OTC) Analgesics Market Size Share 2021 VS 2025 VS 2032 Figure 9. Retail Pharmacies Image Figure 10. Online Pharmacies Image Figure 11. Hospital Pharmacies Image Figure 12. Global Over the Counter (OTC) Analgesics Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Over the Counter (OTC) Analgesics Revenue (2021-2032) & (US$ Million) Figure 14. Global Over the Counter (OTC) Analgesics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Over the Counter (OTC) Analgesics Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Over the Counter (OTC) Analgesics Revenue Market Share by Region (2021-2032) Figure 17. Global Over the Counter (OTC) Analgesics Sales (2021-2032) & (K Units) Figure 18. Global Over the Counter (OTC) Analgesics Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Over the Counter (OTC) Analgesics Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Over the Counter (OTC) Analgesics Sales YoY (2021-2032) & (K Units) Figure 21. Europe Over the Counter (OTC) Analgesics Sales YoY (2021-2032) & (K Units) Figure 22. China Over the Counter (OTC) Analgesics Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Over the Counter (OTC) Analgesics Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Over the Counter (OTC) Analgesics Sales YoY (2021-2032) & (K Units) Figure 25. Global Over the Counter (OTC) Analgesics Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Over the Counter (OTC) Analgesics Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Over the Counter (OTC) Analgesics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Over the Counter (OTC) Analgesics Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Over the Counter (OTC) Analgesics Revenue Market Share by Type (2021-2032) Figure 31. Global Over the Counter (OTC) Analgesics Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Over the Counter (OTC) Analgesics Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Over the Counter (OTC) Analgesics Sales Market Share by Type (2021-2032) Figure 34. Global Over the Counter (OTC) Analgesics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Over the Counter (OTC) Analgesics Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Over the Counter (OTC) Analgesics Revenue Market Share by Application (2021-2032) Figure 37. Global Over the Counter (OTC) Analgesics Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Over the Counter (OTC) Analgesics Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Over the Counter (OTC) Analgesics Sales Market Share by Application (2021-2032) Figure 40. North America Over the Counter (OTC) Analgesics Revenue Share by Type (2021-2032) Figure 41. North America Over the Counter (OTC) Analgesics Sales Share by Type (2021-2032) Figure 42. North America Over the Counter (OTC) Analgesics Revenue Share by Application (2021-2032) Figure 43. North America Over the Counter (OTC) Analgesics Sales Share by Application (2021-2032) Figure 44. North America Over the Counter (OTC) Analgesics Revenue Share by Country (2021-2032) Figure 45. North America Over the Counter (OTC) Analgesics Sales Share by Country (2021-2032) Figure 46. Europe Over the Counter (OTC) Analgesics Revenue Share by Type (2021-2032) Figure 47. Europe Over the Counter (OTC) Analgesics Sales Share by Type (2021-2032) Figure 48. Europe Over the Counter (OTC) Analgesics Revenue Share by Application (2021-2032) Figure 49. Europe Over the Counter (OTC) Analgesics Sales Share by Application (2021-2032) Figure 50. Europe Over the Counter (OTC) Analgesics Revenue Share by Country (2021-2032) Figure 51. Europe Over the Counter (OTC) Analgesics Sales Share by Country (2021-2032) Figure 52. China Over the Counter (OTC) Analgesics Revenue Share by Type (2021-2032) Figure 53. China Over the Counter (OTC) Analgesics Sales Share by Type (2021-2032) Figure 54. China Over the Counter (OTC) Analgesics Revenue Share by Application (2021-2032) Figure 55. China Over the Counter (OTC) Analgesics Sales Share by Application (2021-2032) Figure 56. Asia Over the Counter (OTC) Analgesics Revenue Share by Type (2021-2032) Figure 57. Asia Over the Counter (OTC) Analgesics Sales Share by Type (2021-2032) Figure 58. Asia Over the Counter (OTC) Analgesics Revenue Share by Application (2021-2032) Figure 59. Asia Over the Counter (OTC) Analgesics Sales Share by Application (2021-2032) Figure 60. Asia Over the Counter (OTC) Analgesics Revenue Share by Country (2021-2032) Figure 61. Asia Over the Counter (OTC) Analgesics Sales Share by Country (2021-2032) Figure 62. SAMEA Over the Counter (OTC) Analgesics Revenue Share by Type (2021-2032) Figure 63. SAMEA Over the Counter (OTC) Analgesics Sales Share by Type (2021-2032) Figure 64. SAMEA Over the Counter (OTC) Analgesics Revenue Share by Application (2021-2032) Figure 65. SAMEA Over the Counter (OTC) Analgesics Sales Share by Application (2021-2032) Figure 66. SAMEA Over the Counter (OTC) Analgesics Revenue Share by Country (2021-2032) Figure 67. SAMEA Over the Counter (OTC) Analgesics Sales Share by Country (2021-2032) Figure 68. Over the Counter (OTC) Analgesics Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Over the Counter (OTC) Analgesics Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Capsule
  • Other
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Takeda Pharmaceutical Company Limited.
  • Sanofi SA
  • Johnson & Johnson
  • Novartis
  • Pfizer
  • Bayer AG
  • AstraZeneca
  • Sun Pharma
  • Reckitt Benckiser Group PLC
  • GlaxoSmithKline PLC
  • Boehringer Ingelheim International GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Over the Counter (OTC) Analgesics Market by Type
  3. 1.2.1 Global Over the Counter (OTC) Analgesics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Tablet
  5. 1.2.3 Capsule
  6. 1.2.4 Other
  7. 1.3 Over the Counter (OTC) Analgesics Market by Application
  8. 1.3.1 Global Over the Counter (OTC) Analgesics Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Retail Pharmacies
  10. 1.3.3 Online Pharmacies
  11. 1.3.4 Hospital Pharmacies
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Over the Counter (OTC) Analgesics Market Dynamics
  1. 2.1 Over the Counter (OTC) Analgesics Industry Trends
  2. 2.2 Over the Counter (OTC) Analgesics Industry Drivers
  3. 2.3 Over the Counter (OTC) Analgesics Industry Opportunities and Challenges
  4. 2.4 Over the Counter (OTC) Analgesics Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Over the Counter (OTC) Analgesics Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Over the Counter (OTC) Analgesics Revenue by Region
  3. 3.2.1 Global Over the Counter (OTC) Analgesics Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Over the Counter (OTC) Analgesics Revenue by Region (2021-2026)
  5. 3.2.3 Global Over the Counter (OTC) Analgesics Revenue by Region (2027-2032)
  6. 3.2.4 Global Over the Counter (OTC) Analgesics Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Over the Counter (OTC) Analgesics Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Over the Counter (OTC) Analgesics Sales by Region
  9. 3.4.1 Global Over the Counter (OTC) Analgesics Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Over the Counter (OTC) Analgesics Sales by Region (2021-2026)
  11. 3.4.3 Global Over the Counter (OTC) Analgesics Sales by Region (2027-2032)
  12. 3.4.4 Global Over the Counter (OTC) Analgesics Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Over the Counter (OTC) Analgesics Revenue by Manufacturers
  2. 4.1.1 Global Over the Counter (OTC) Analgesics Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Over the Counter (OTC) Analgesics Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Over the Counter (OTC) Analgesics Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Over the Counter (OTC) Analgesics Sales by Manufacturers
  6. 4.2.1 Global Over the Counter (OTC) Analgesics Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Over the Counter (OTC) Analgesics Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Over the Counter (OTC) Analgesics Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Over the Counter (OTC) Analgesics Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Over the Counter (OTC) Analgesics Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Over the Counter (OTC) Analgesics Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Over the Counter (OTC) Analgesics Manufacturers, Product Type & Application
  13. 4.7 Global Over the Counter (OTC) Analgesics Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Over the Counter (OTC) Analgesics Market CR5 and HHI
  16. 4.8.2 2025 Over the Counter (OTC) Analgesics Tier 1, Tier 2, and Tier 3
5 Over the Counter (OTC) Analgesics Market by Type
  1. 5.1 Global Over the Counter (OTC) Analgesics Revenue by Type
  2. 5.1.1 Global Over the Counter (OTC) Analgesics Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Over the Counter (OTC) Analgesics Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Over the Counter (OTC) Analgesics Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Over the Counter (OTC) Analgesics Sales by Type
  6. 5.2.1 Global Over the Counter (OTC) Analgesics Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Over the Counter (OTC) Analgesics Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Over the Counter (OTC) Analgesics Sales Market Share by Type (2021-2032)
  9. 5.3 Global Over the Counter (OTC) Analgesics Price by Type
6 Over the Counter (OTC) Analgesics Market by Application
  1. 6.1 Global Over the Counter (OTC) Analgesics Revenue by Application
  2. 6.1.1 Global Over the Counter (OTC) Analgesics Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Over the Counter (OTC) Analgesics Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Over the Counter (OTC) Analgesics Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Over the Counter (OTC) Analgesics Sales by Application
  6. 6.2.1 Global Over the Counter (OTC) Analgesics Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Over the Counter (OTC) Analgesics Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Over the Counter (OTC) Analgesics Sales Market Share by Application (2021-2032)
  9. 6.3 Global Over the Counter (OTC) Analgesics Price by Application
7 Company Profiles
  1. 7.1 Takeda Pharmaceutical Company Limited.
  2. 7.1.1 Takeda Pharmaceutical Company Limited. Company Information
  3. 7.1.2 Takeda Pharmaceutical Company Limited. Business Overview
  4. 7.1.3 Takeda Pharmaceutical Company Limited. Over the Counter (OTC) Analgesics Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Takeda Pharmaceutical Company Limited. Over the Counter (OTC) Analgesics Product Portfolio
  6. 7.1.5 Takeda Pharmaceutical Company Limited. Recent Developments
  7. 7.2 Sanofi SA
  8. 7.2.1 Sanofi SA Company Information
  9. 7.2.2 Sanofi SA Business Overview
  10. 7.2.3 Sanofi SA Over the Counter (OTC) Analgesics Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sanofi SA Over the Counter (OTC) Analgesics Product Portfolio
  12. 7.2.5 Sanofi SA Recent Developments
  13. 7.3 Johnson & Johnson
  14. 7.3.1 Johnson & Johnson Company Information
  15. 7.3.2 Johnson & Johnson Business Overview
  16. 7.3.3 Johnson & Johnson Over the Counter (OTC) Analgesics Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Johnson & Johnson Over the Counter (OTC) Analgesics Product Portfolio
  18. 7.3.5 Johnson & Johnson Recent Developments
  19. 7.4 Novartis
  20. 7.4.1 Novartis Company Information
  21. 7.4.2 Novartis Business Overview
  22. 7.4.3 Novartis Over the Counter (OTC) Analgesics Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Novartis Over the Counter (OTC) Analgesics Product Portfolio
  24. 7.4.5 Novartis Recent Developments
  25. 7.5 Pfizer
  26. 7.5.1 Pfizer Company Information
  27. 7.5.2 Pfizer Business Overview
  28. 7.5.3 Pfizer Over the Counter (OTC) Analgesics Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Pfizer Over the Counter (OTC) Analgesics Product Portfolio
  30. 7.5.5 Pfizer Recent Developments
  31. 7.6 Bayer AG
  32. 7.6.1 Bayer AG Company Information
  33. 7.6.2 Bayer AG Business Overview
  34. 7.6.3 Bayer AG Over the Counter (OTC) Analgesics Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Bayer AG Over the Counter (OTC) Analgesics Product Portfolio
  36. 7.6.5 Bayer AG Recent Developments
  37. 7.7 AstraZeneca
  38. 7.7.1 AstraZeneca Company Information
  39. 7.7.2 AstraZeneca Business Overview
  40. 7.7.3 AstraZeneca Over the Counter (OTC) Analgesics Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 AstraZeneca Over the Counter (OTC) Analgesics Product Portfolio
  42. 7.7.5 AstraZeneca Recent Developments
  43. 7.8 Sun Pharma
  44. 7.8.1 Sun Pharma Company Information
  45. 7.8.2 Sun Pharma Business Overview
  46. 7.8.3 Sun Pharma Over the Counter (OTC) Analgesics Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Sun Pharma Over the Counter (OTC) Analgesics Product Portfolio
  48. 7.8.5 Sun Pharma Recent Developments
  49. 7.9 Reckitt Benckiser Group PLC
  50. 7.9.1 Reckitt Benckiser Group PLC Company Information
  51. 7.9.2 Reckitt Benckiser Group PLC Business Overview
  52. 7.9.3 Reckitt Benckiser Group PLC Over the Counter (OTC) Analgesics Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Reckitt Benckiser Group PLC Over the Counter (OTC) Analgesics Product Portfolio
  54. 7.9.5 Reckitt Benckiser Group PLC Recent Developments
  55. 7.10 GlaxoSmithKline PLC
  56. 7.10.1 GlaxoSmithKline PLC Company Information
  57. 7.10.2 GlaxoSmithKline PLC Business Overview
  58. 7.10.3 GlaxoSmithKline PLC Over the Counter (OTC) Analgesics Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 GlaxoSmithKline PLC Over the Counter (OTC) Analgesics Product Portfolio
  60. 7.10.5 GlaxoSmithKline PLC Recent Developments
  61. 7.11 Boehringer Ingelheim International GmbH
  62. 7.11.1 Boehringer Ingelheim International GmbH Company Information
  63. 7.11.2 Boehringer Ingelheim International GmbH Business Overview
  64. 7.11.3 Boehringer Ingelheim International GmbH Over the Counter (OTC) Analgesics Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Boehringer Ingelheim International GmbH Over the Counter (OTC) Analgesics Product Portfolio
  66. 7.11.5 Boehringer Ingelheim International GmbH Recent Developments
8 North America
  1. 8.1 North America Over the Counter (OTC) Analgesics Market Size by Type
  2. 8.1.1 North America Over the Counter (OTC) Analgesics Revenue by Type (2021-2032)
  3. 8.1.2 North America Over the Counter (OTC) Analgesics Sales by Type (2021-2032)
  4. 8.1.3 North America Over the Counter (OTC) Analgesics Price by Type (2021-2032)
  5. 8.2 North America Over the Counter (OTC) Analgesics Market Size by Application
  6. 8.2.1 North America Over the Counter (OTC) Analgesics Revenue by Application (2021-2032)
  7. 8.2.2 North America Over the Counter (OTC) Analgesics Sales by Application (2021-2032)
  8. 8.2.3 North America Over the Counter (OTC) Analgesics Price by Application (2021-2032)
  9. 8.3 North America Over the Counter (OTC) Analgesics Market Size by Country
  10. 8.3.1 North America Over the Counter (OTC) Analgesics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Over the Counter (OTC) Analgesics Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Over the Counter (OTC) Analgesics Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Over the Counter (OTC) Analgesics Market Size by Type
  2. 9.1.1 Europe Over the Counter (OTC) Analgesics Revenue by Type (2021-2032)
  3. 9.1.2 Europe Over the Counter (OTC) Analgesics Sales by Type (2021-2032)
  4. 9.1.3 Europe Over the Counter (OTC) Analgesics Price by Type (2021-2032)
  5. 9.2 Europe Over the Counter (OTC) Analgesics Market Size by Application
  6. 9.2.1 Europe Over the Counter (OTC) Analgesics Revenue by Application (2021-2032)
  7. 9.2.2 Europe Over the Counter (OTC) Analgesics Sales by Application (2021-2032)
  8. 9.2.3 Europe Over the Counter (OTC) Analgesics Price by Application (2021-2032)
  9. 9.3 Europe Over the Counter (OTC) Analgesics Market Size by Country
  10. 9.3.1 Europe Over the Counter (OTC) Analgesics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Over the Counter (OTC) Analgesics Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Over the Counter (OTC) Analgesics Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Over the Counter (OTC) Analgesics Market Size by Type
  2. 10.1.1 China Over the Counter (OTC) Analgesics Revenue by Type (2021-2032)
  3. 10.1.2 China Over the Counter (OTC) Analgesics Sales by Type (2021-2032)
  4. 10.1.3 China Over the Counter (OTC) Analgesics Price by Type (2021-2032)
  5. 10.2 China Over the Counter (OTC) Analgesics Market Size by Application
  6. 10.2.1 China Over the Counter (OTC) Analgesics Revenue by Application (2021-2032)
  7. 10.2.2 China Over the Counter (OTC) Analgesics Sales by Application (2021-2032)
  8. 10.2.3 China Over the Counter (OTC) Analgesics Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Over the Counter (OTC) Analgesics Market Size by Type
  2. 11.1.1 Asia Over the Counter (OTC) Analgesics Revenue by Type (2021-2032)
  3. 11.1.2 Asia Over the Counter (OTC) Analgesics Sales by Type (2021-2032)
  4. 11.1.3 Asia Over the Counter (OTC) Analgesics Price by Type (2021-2032)
  5. 11.2 Asia Over the Counter (OTC) Analgesics Market Size by Application
  6. 11.2.1 Asia Over the Counter (OTC) Analgesics Revenue by Application (2021-2032)
  7. 11.2.2 Asia Over the Counter (OTC) Analgesics Sales by Application (2021-2032)
  8. 11.2.3 Asia Over the Counter (OTC) Analgesics Price by Application (2021-2032)
  9. 11.3 Asia Over the Counter (OTC) Analgesics Market Size by Country
  10. 11.3.1 Asia Over the Counter (OTC) Analgesics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Over the Counter (OTC) Analgesics Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Over the Counter (OTC) Analgesics Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Over the Counter (OTC) Analgesics Market Size by Type
  2. 12.1.1 SAMEA Over the Counter (OTC) Analgesics Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Over the Counter (OTC) Analgesics Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Over the Counter (OTC) Analgesics Price by Type (2021-2032)
  5. 12.2 SAMEA Over the Counter (OTC) Analgesics Market Size by Application
  6. 12.2.1 SAMEA Over the Counter (OTC) Analgesics Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Over the Counter (OTC) Analgesics Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Over the Counter (OTC) Analgesics Price by Application (2021-2032)
  9. 12.3 SAMEA Over the Counter (OTC) Analgesics Market Size by Country
  10. 12.3.1 SAMEA Over the Counter (OTC) Analgesics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Over the Counter (OTC) Analgesics Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Over the Counter (OTC) Analgesics Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Over the Counter (OTC) Analgesics Value Chain Analysis
  2. 13.1.1 Over the Counter (OTC) Analgesics Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Over the Counter (OTC) Analgesics Production Mode & Process
  6. 13.2 Over the Counter (OTC) Analgesics Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Over the Counter (OTC) Analgesics Distributors
  9. 13.2.3 Over the Counter (OTC) Analgesics Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst